Loading…
Bruker Corporation is projected to rise to $61.49 by 2027, a +26% move from its current price of $48.62. BRKR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $47.34 | $48.63 | $49.95 | +0.01% |
| May 30 | $46.83 | $48.63 | $50.51 | +0.03% |
| May 31 | $46.44 | $48.64 | $50.95 | +0.04% |
| Jun 1 | $46.11 | $48.65 | $51.32 | +0.05% |
| Jun 2 | $45.83 | $48.65 | $51.65 | +0.07% |
| Jun 3 | $45.57 | $48.66 | $51.96 | +0.08% |
| Jun 4 | $45.34 | $48.67 | $52.24 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $45.34 | $48.67 | $52.24 | +0.09% |
| Week 2 | $44.07 | $48.71 | $53.84 | +0.19% |
| Week 3 | $43.13 | $48.76 | $55.12 | +0.28% |
| Week 4 | $42.36 | $48.80 | $56.23 | +0.37% |
| Week 5 | $41.69 | $48.85 | $57.23 | +0.47% |
| Week 6 | $41.10 | $48.89 | $58.16 | +0.56% |
| Week 7 | $40.57 | $48.94 | $59.03 | +0.66% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bruker Corporation is a healthcare company that develops, manufactures, and distributes scientific instruments and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Bruker offers a wide range of products and services across life sciences, analytical and diagnostic tools, and lab automation, including magnetic resonance spectroscopy, preclinical imaging, and innovative NMR and EPR products, as well as X-ray instruments and microscopy tools. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Bruker is currently trading at $45.69 with a market cap of $6.96B. It is ranked 1112 in market capitalization terms.
The price outlook is described by a multi-year forecast that shows a neutral stance in 2026, then bullish momentum from 2027 onward, with an average price rising from $56.93 in 2027 to $292.73 by 2050 and a max forecast of $537.59 in 2050.
The stock’s near-term technical picture features a bullish posture, with a current price near key resistance at $45.69, supported by a 30-day range of $38.30 to $54.50 and RSI(14) at 70. The 50-day SMA is $38.47 and the 200-day SMA is $39.83, with a nearby support at $34.29 and resistance at $45.69.
A major floor 39.3% below — a decisive break under it would weaken the trend.
The nearest floor, 29.5% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 19.6% above — clearing it would confirm fresh momentum.
Key BRKR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BRKR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $46.09 | Buy | $46.42 | Buy |
| MA 10 | $44.67 | Buy | $45.03 | Buy |
| MA 20 | $42.35 | Buy | $43.17 | Buy |
| MA 50 | $39.05 | Buy | $40.99 | Buy |
| MA 100 | $41.23 | Buy | $40.70 | Buy |
| MA 200 | $40.00 | Buy | $41.46 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 73.37 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 140.96 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.46 | Buy |
| ROC (12) | 10.10 | Buy |
| Bollinger %B (20,2) | 0.92 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.65 | Buy |
| Awesome (5,34) | 5.30 | Buy |
| Ultimate (7,14,28) | 85.09 | Sell |
| Momentum (10) | 3.89 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 47.64 | Buy |
| ADX (14) | 25.89 | Buy |
| ATR (14) | 1.04 | Info |
The 30-day technical picture is bullish, with RSI(14) at 70 and momentum shown by the price trading above short- and intermediate-term moving averages. The SMA50 sits at $38.47 and the SMA200 at $39.83, indicating near-term upside potential.
Support is listed at $34.29 and resistance at $45.69, reflecting a defined trading range. The 30-day range spans $38.30 to $54.50, placing the current price near the upper end and just below the resistance level at $45.69.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $32.76 | $48.62 | $72.27 | 0% | Neutral | |
| $48.86 | $61.49 | $81.92 | +26% | Bullish | |
| $48.51 | $62.70 | $86.52 | +29% | Bullish | |
| $52.26 | $69.06 | $97.98 | +42% | Bullish | |
| $52.61 | $70.90 | $102.99 | +46% | Bullish | |
| $58.52 | $80.30 | $119.06 | +65% | Bullish | |
| $69.04 | $96.33 | $145.51 | +98% | Bullish | |
| $73.31 | $103.91 | $159.62 | +114% | Bullish | |
| $77.45 | $111.44 | $173.85 | +129% | Bullish | |
| $76.67 | $111.91 | $177.12 | +130% | Bullish | |
| $105.72 | $164.69 | $276.90 | +239% | Bullish | |
| $199.91 | $348.31 | $639.75 | +616% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $32.76 | $48.62 | $57.34 | +0.00% |
| June 2026 | $42.21 | $49.55 | $59.53 | +1.90% |
| July 2026 | $41.58 | $49.21 | $59.92 | -0.67% |
| August 2026 | $42.76 | $50.94 | $62.65 | +3.50% |
| September 2026 | $44.56 | $53.37 | $66.18 | +4.77% |
| October 2026 | $44.87 | $54.00 | $67.47 | +1.18% |
| November 2026 | $45.26 | $54.71 | $68.81 | +1.32% |
| December 2026 | $47.06 | $57.12 | $72.27 | +4.39% |
Click any year to see its month-by-month BRKR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BRKR is projected to trade between $32.76 and $72.27, averaging $48.62 — a potential gain of 0% from today's $48.62. Price action looks broadly range-bound.
Bruker Corporation's 2027 outlook centres on $61.49, within a $48.86 to $81.92 range. That is up +26% on the projected 2026 average. That marks a +26% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, BRKR could reach as high as $86.52, with a base case around $62.70 and support toward $48.51 — roughly +29% from $48.62. Momentum favours further upside here.
Expect BRKR to range from $52.26 to $97.98 through 2029. The $69.06 average target implies a +42% move from current prices. That is up +10% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The BRKR price prediction for 2030 points to an average of $70.90 (low $52.61, high $102.99) — a potential gain of +46% on today's $48.62. Momentum favours further upside here.
In 2031, BRKR is projected to trade between $58.52 and $119.06, averaging $80.30 — a potential gain of +65% from today's $48.62. That is up +13% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Bruker Corporation's 2032 outlook centres on $96.33, within a $69.04 to $145.51 range. That is up +20% on the projected 2031 average. That marks a +98% change versus current levels. Momentum favours further upside here.
By 2033, BRKR could reach as high as $159.62, with a base case around $103.91 and support toward $73.31 — roughly +114% from $48.62. Buyers look set to stay in control over this stretch.
Expect BRKR to range from $77.45 to $173.85 through 2034. The $111.44 average target implies a +129% move from current prices. That is up +7% on the projected 2033 average. Momentum favours further upside here.
The BRKR price prediction for 2035 points to an average of $111.91 (low $76.67, high $177.12) — a potential gain of +130% on today's $48.62. Buyers look set to stay in control over this stretch.
In 2040, BRKR is projected to trade between $105.72 and $276.90, averaging $164.69 — a potential gain of +239% from today's $48.62. That is up +47% on the projected 2035 average. Momentum favours further upside here.
Bruker Corporation's 2050 outlook centres on $348.31, within a $199.91 to $639.75 range. That is up +111% on the projected 2040 average. That marks a +616% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in BRKR today (≈ 20.567668 BRKR) could be worth
$7,163.94
+$6,163.94 (+616%) by 2050 · US Dollar
Based on the average projected BRKR price of $348.31 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BRKRwould be worth at today's price.
$1,000 invested in BRKR on May 27, 2025 (≈ 26.917899 BRKR) would be worth
$1,308.75
+$308.75 (+30.9%) today · 1.31× · US Dollar
Based on a BRKR entry price of $37.15 vs. today's $48.62.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $44.26 | $1,098.51 | +9.9% |
| 1 month ago | $36.53 | $1,330.96 | +33.1% |
| 3 months ago | $41.02 | $1,185.28 | +18.5% |
| 6 months ago | $48.81 | $996.11 | -0.4% |
| 1 year ago | $37.15 | $1,308.75 | +30.9% |
| All time (5.0y) ago | $69.03 | $704.33 | -29.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BRKR forecast.
Our base-case forecast reaches $97.00 around 2033.
Implied market cap at $97.00: $14.77B
The multi-year forecast shows sustained bullish momentum beginning in 2027, with an average price of $56.93 in 2027, $57.69 in 2028, $63.37 in 2029, and $63.70 in 2030, with respective max values of $75.88, $79.64, $89.93, and $92.55 and ROI figures of 24.6%, 26.3%, 38.7%, and 39.4%.
From 2031 onward, the outlook remains bullish, with 2031 avg $71.31 and max $105.74 (ROI 56.1%), 2032 avg $85.58 (ROI 87.3%), 2033 avg $91.43 (ROI 100.1%), 2034 avg $98.07 (ROI 114.7%), and 2035 avg $98.17 (ROI 114.9%). The bullish trend continues into 2040, where the forecast shows avg $141.63 (ROI 210%) and max $238.11, and into 2050 with avg $292.73 (ROI 540.7%) and max $537.59.
These figures are estimates and not guarantees, and actual results depend on market conditions and other factors. The outlook indicates meaningful upside potential alongside the inherent uncertainties of investing.
Tap a question to reveal the answer.
Avg price is forecast at $63.70, with a min of $47.26 and a max of $92.55. The ROI is 39.4% and sentiment is BULLISH.
Forecasts project bullish sentiment from 2027 onward, with 2027 avg $56.93 (ROI 24.6%), 2028 avg $57.69 (ROI 26.3%), 2029 avg $63.37 (ROI 38.7%), 2030 avg $63.70 (ROI 39.4%), 2040 avg $141.63 (ROI 210%), and 2050 avg $292.73 (ROI 540.7%).
Yes. The 2031 max is $105.74, which exceeds $100 (2031 min $51.96, avg $71.31). The 2030 max is $92.55, which does not reach $100.
Current price is $45.69 and market cap is $6.96B. The rank shown is 1112.
2040: avg $141.63, min $90.92, max $238.11; ROI 210%; sentiment BULLISH. 2050: avg $292.73, min $168.04, max $537.59; ROI 540.7%; sentiment BULLISH.
Bruker Corporation Community Discussion
0Share your Bruker Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.